DXCM News and Press, DexCom Inc. From 12/12/22

New Digital Diabetes Care Program combines Dexcom G6 real-time continuous glucose monitoring (rtCGM) with enhanced virtual diabetes management support services Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (rtCGM), announced today its partnership with Gr...

With the Nasdaq Composite still firmly entrenched in bear market territory, if you're feeling discouraged about the state of your portfolio and the performance of some of your favorite stocks, you're certainly not alone. However, even in volatile markets, compelling buying opportunities remai...

DexCom ( NASDAQ: DXCM ) on Thursday said the U.S. FDA had cleared the use of its continuous glucose monitoring system for people with all types of diabetes aged two years and older. Shares of the diabetes medical device maker rose 6% to $124.95 in premarket trading. The approv...

Dexcom G7 is now cleared in the U.S. for people with all Types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution With an overall MARD of 8.2%, Dexcom G7 is the most accurate CGM cleared by the FDA, 1 building ...

With so many companies across a wide variety of sectors suffering the wrath of volatile investor sentiment, it's easy to feel discouraged about the prospects of your portfolio in the current moment. However, when you're investing in quality stocks for five years, 10 years, 15 years -- or even lon...

Dexcom, Inc. (NASDAQ: DXCM), - November is National Diabetes Awareness Month, time to bring attention to the prevalence and risk of diabetes within our diverse Canadian population, and to profile innovative strategies for prevention and management. In this context, Dexcom Canada is pleased to...

Over the past 10 months, several high-profile stock splits helped animate an already lively stock market. One of them was that of the medical device expert DexCom (NASDAQ: DXCM) , which completed a 4-for-1 stock split in June. Of course, stock splits don't fundamentally change t...

Dexcom Warriors Henry Slade, Roxy Horner, Sheku Kanneh-Mason and Eoin Costelloe unveil their custom Dexcom continuous glucose monitor (CGM) patches to tell their ‘Diabetes Story’ On World Diabetes Day and throughout the month of November, people with diabetes and the...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When searching for growth stocks to buy, investors should first ascertain what growth means to them. It varies from person to person.  I might define growth stocks as companies growing sales by 20% annually. You m...

A struggling economy, rising interest rates, and negative results from high-profile corporations continue to drag the stock market down. And although medical device specialist DexCom (NASDAQ: DXCM) hasn't entirely escaped the bloodbath, the company has been doing much better in the ...